• Exchange: Tokyo
  • Sector: Health Care
  • Industry: Health Care Facilities/Srvcs
  • Sub-Industry: Health Care Services

Trans Genic Inc

+ Add to Watchlist

2342:JP

390 JPY 1 0.26%

As of 02:00:00 ET on 04/17/2014.

Snapshot for Trans Genic Inc (2342)

Open: 394 Day's Range: 388 - 396 Volume: 14,700
Previous Close: 391 52wk Range: 368 - 1,198 1-Yr Rtn: -52.55%

Stock Chart for 2342

No chart data available.
  • 2342:JP 390
  • 1D
  • 1M
  • 1Y
391
Interactive 2342 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 2342

Current P/E Ratio (ttm) -
Estimated P/E(03/2014) -
Relative P/E vs. TPX -
Earnings Per Share (JPY) (ttm) -0.0700
Est. EPS (JPY) (03/2014) -8.8000
Est. PEG Ratio -
Market Cap (M JPY) 5,313.40
Shares Outstanding (M) 13.62
30 Day Average Volume 55,183
Price/Book (mrq) 2.0023
Price/Sale (ttm) 4.1061
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/09/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 2342

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for 2342

TRANS GENIC INC. develops, produces, and sells specific idiotype bearing antibody (bio reagent). The Company also develops mutant mice and sells mice' genetic function analysis data.

Kenji FukunagaPresidentKenichi YamamuraDirector
Tamami SakamotoDirectorYasushi FunabashiDirector
More Company Profile & Key Executives for 2342

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil